Philip Bonomi to Recombinant Fusion Proteins
This is a "connection" page, showing publications Philip Bonomi has written about Recombinant Fusion Proteins.
Connection Strength
0.021
-
A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer. Am J Clin Oncol. 2009 Jun; 32(3):269-73.
Score: 0.021
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.